The post Coinbase Launches Token Sale Platform for Investors Ahead of MON Launch appeared first on Coinpedia Fintech News Coinbase has announced the launch of a new token sales platform that will let everyday investors buy digital tokens even before they are officially listed on its exchange.  The move is designed to make token launches more fair, transparent, and accessible.  Read on to know more about the details. Monthly Token Sales Open to All …The post Coinbase Launches Token Sale Platform for Investors Ahead of MON Launch appeared first on Coinpedia Fintech News Coinbase has announced the launch of a new token sales platform that will let everyday investors buy digital tokens even before they are officially listed on its exchange.  The move is designed to make token launches more fair, transparent, and accessible.  Read on to know more about the details. Monthly Token Sales Open to All …

Coinbase Launches Token Sale Platform for Investors Ahead of MON Launch

2025/11/11 19:09
3 min read
Coinbase The Blue Carpet

The post Coinbase Launches Token Sale Platform for Investors Ahead of MON Launch appeared first on Coinpedia Fintech News

Coinbase has announced the launch of a new token sales platform that will let everyday investors buy digital tokens even before they are officially listed on its exchange. 

The move is designed to make token launches more fair, transparent, and accessible. 

Read on to know more about the details.

Monthly Token Sales Open to All

Under this initiative, Coinbase will host roughly one token sale per month, where investors can submit purchase requests during a one-week window. The token sales prioritizes broad participation over large holders. Smaller orders are filled first, and users who sell within 30 days may get reduced allocations in future sales, rewarding long-term supporters. Payments will be made in USDC. 

The first token to launch on the platform will be MON, the native token of the Monad blockchain. 

The token sale runs from November 17–22, 2025. It will offer up to 7.5 billion tokens, about 7.5% of the total supply, priced at $0.025 each, with an implied valuation of the project at roughly $2.5 billion.

To participate, users should have verified Coinbase accounts and meet the platform requirements.

Strict Rules in Place

Coinbase’s framework introduces strong transparency requirements. Issuers must provide clear disclosures about their project, team, and tokenomics. Founders and affiliates are restricted from selling tokens for six months after the sale. 

Issuers pay a fee based on funds raised – investors, however, won’t pay for participation. 

How MON Tokens Will Be Distributed

The MON token’s total supply is capped at 100 billion MON tokens, with 49.4B (49.4%) unlocked at mainnet launch. The token distribution is as follows:

  • Ecosystem development: 38.5%
  • Team: 27%
  • Investors: 19.7%
  • Public sale: 7.5%
  • Category Labs Treasury: 4%
  • Airdrop: 3.3%

Monad remains focused on growth and community participation. 

Token Sale Brings More Transparency

The MON token sale reveals a new level of transparency for a crypto launch. It’s the first large-scale issuance to fully disclose its market makers, loan sizes, and execution periods.

The issuer, MF Services (BVI) Ltd., has signed token loan agreements with top market makers like Auros and Wintermute. A third-party monitor, Coinwatch, will track how these tokens are used, including checking for idle balances.

The issuer also plans to use a small portion of the total MON supply, about 0.2%, to provide initial liquidity on decentralized exchanges (DEXs). This is a small, short-term measure to make it easier for people to buy and sell MON and help keep prices stable.

A Strong Comeback for Public Token Sales 

Coinbase notes that this initiative is meant to solve a common problem for new crypto projects, which is getting tokens into the hands of real users while still building market liquidity. 

This marks the first time since 2018 that U.S. investors can easily join public token sales, after years of regulatory uncertainty around ICOs.

Coinbase is clearly setting a new standard for how projects go to market, by creating a balanced and transparent token sales platform for both issuers and users.

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0.003233
$0.003233$0.003233
-0.58%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26